Annual Net Margin
N/A
December 31, 2024
Summary
- PLRX annual net profit margin is not available.
Performance
PLRX Net Margin Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Net Margin
N/A
December 31, 2024
Summary
- PLRX quarterly net profit margin is not available.
Performance
PLRX Quarterly Net Margin Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Net Margin Formula
Net Margin = Net Income
Revenue ✕ 100%
Revenue ✕ 100%
PLRX Net Margin Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | - | - |
3 y3 years | - | - |
5 y5 years | - | - |
PLRX Net Margin Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | ||||
5 y | 5-year | ||||
alltime | all time |
Pliant Therapeutics Net Margin History
Date | Annual | Quarterly |
---|---|---|
Dec 2023 | -10.21 K%(+701.9%) | - |
Jun 2023 | - | -16.61 K%(+489.2%) |
Mar 2023 | - | -2818.92%(+58.0%) |
Dec 2022 | -1273.32%(-0.9%) | -1784.22%(-13.6%) |
Sep 2022 | - | -2065.79%(+248.8%) |
Jun 2022 | - | -592.22%(-73.7%) |
Mar 2022 | - | -2249.80%(+83.3%) |
Dec 2021 | -1284.51% | -1227.16%(-26.9%) |
Date | Annual | Quarterly |
---|---|---|
Sep 2021 | - | -1679.81%(+31.6%) |
Jun 2021 | - | -1276.19%(+21.4%) |
Mar 2021 | - | -1051.33%(+146.7%) |
Dec 2020 | -99.32%(+8847.7%) | -426.14%(+24.1%) |
Sep 2020 | - | -343.46%(-27.3%) |
Jun 2020 | - | -472.25%(-1339.2%) |
Mar 2020 | - | 38.11%(-48.4%) |
Dec 2019 | -1.11% | 73.91% |
FAQ
- What is the all time high annual net margin for Pliant Therapeutics?
- What is the all time high quarterly net margin for Pliant Therapeutics?
What is the all time high annual net margin for Pliant Therapeutics?
Pliant Therapeutics all-time high annual net profit margin is -1.11%
What is the all time high quarterly net margin for Pliant Therapeutics?
Pliant Therapeutics all-time high quarterly net profit margin is 73.91%